Susquehanna International Group, LLP Indaptus Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Indaptus Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 17,829 shares of INDP stock, worth $13,371. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,829Holding current value
$13,371% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding INDP
# of Institutions
20Shares Held
638KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$192,1980.0% of portfolio
-
Investment House LLC Las Vegas, NV100KShares$75,1320.0% of portfolio
-
Geode Capital Management, LLC Boston, MA82.1KShares$61,5880.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$34,0020.01% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ43.9KShares$32,9400.0% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $6.19M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...